Assessing the outcomes of HIV-infected persons receiving treatment for Kaposi sarcoma in Conakry-Guinea.
Cavin Epie BekoloMohamed M SoumahOusseni W TiemtoreAbdourahimi DialloJoseph-Desire YumaLetizia Di StefanoCarol MetcalfMohamed CissePublished in: BMC cancer (2017)
There has been an increased access to KS treatment. The overall response rate is 52.4%, which is considered a satisfactory result. Poor outcomes were common and were largely due to late presentation and defaulting on treatment. Efforts towards early HIV/KS diagnosis and adherence to a full round of chemotherapy are needed for optimising outcomes. Newer drugs may be required for patients previously exposed to chemotherapy.